期刊文献+

维持性血液透析患者透析过程相关高血压的影响因素 被引量:14

Influence factors of intradialytic hypertension in maintenance hemodialysis patients
原文传递
导出
摘要 目的探讨维持性血液透析患者透析过程相关高血压(IDH)的影响因素。方法入选2010-01-01-2010-12-31福建医科大学附属第一医院肾内科行维持性血液透析的终末期肾脏病患者53例(1年内共进行6890次血液透析),探讨透析过程患者的尿素清除指数(Kt/v)、透析间期体质量增长量(IDWG)、超滤率、甲状旁腺素、促红细胞生成素、平均住院次数、心脑血管疾病并发症发生率等与IDH的关系。根据IDH发生次数分为≥3次(A组,n=19)和≤2次(B组,n=34)。结果与B组比较,A组的透析频率[(2.1±0.3)比(3.0±0.7)次/周]、Kt/v[(0.8±0.1)比(1.3±0.1)]、血红蛋白[(96.4±3.8)比(102.1±2.1)g/L]均较低(P<0.05),而透析前后收缩压和舒张压差值[收缩压(26.4±11.0)比(8.2±6.8)mmHg;舒张压(10.2±4.8)比(4.0±1.2)mmHg]、IDWG[(3.8±1.2)比(2.1±0.9)kg]、超滤率[(14.2±0.2)比(9.1±0.4)mL/(h·kg)]、甲状旁腺素[(564.5±68.7)比(365.9±46.9)ng/L]、促红细胞生成素治疗比例(100%比85.3%)及治疗剂量[(10000±1546)比(8856±1287)U/W]、平均住院次数[(0.7±0.2)比(0.3±0.3)次/年]、心脑血管疾病并发症发生率(64%比12%)均较高(P<0.05)。就单次透析而言,与发生IDH比较,未发生IDH患者的IDWG、超滤率、透析期间平均心率、透析前平均动脉压均较低(P<0.05)。多因素Logistic回归分析显示,IDH影响因素分别为IDWG、透析频率、透析期间平均心率、透析前平均动脉压、超滤率。结论 IDH与IDWG、透析前平均动脉压、透析期间平均心率、透析频率、超滤率相关。 Objective To investigate the influence factors of intradialytic hypertension(IDH) in maintenance hemodi- alysis patients. Methods A total of fifty three patients with end-stage kidney disease, who underwent hemodialy- sis (6890 times a year) in the First Affiliated Hospital of Fujian Medical from January 1, 2010 to December 31, 2010, were enrolled. The correlation between IDH and the outcome measures, including urea clearance index (Kt/v), interdialytic weight gain (IDWG), uhrafihration (UF) rate, intact parathyroid hormone (iPTH ), erythropoietin, average hospitalization rate, incidence of complications of cardiovascular and cerebrovascular disease, in dialysis were investigated. According the occurrences of IDH, they were divided into group A (≥3 times, n=19) and group B (≤2 times, n = 34 ). Results Compared with those of group B, the dialysis frequency [,( 2. ± 0.3 ) vs ( 3.0 ± 0.7)times/week], Kt/v [(0.8±0.1) vs (1.3±0.1)], hemoglobin(HGB) [(96.4±3.8) vs (102.1±2. 1) g/L] of group A were lower (P〈0.05). While blood pressure change after dialysis variations [systolic blood pressure: (26.4±11.0) vs (8.2±6.8) ; diastolic blood pressure: (10.2±4.8) vs (4.04-1.2)mm Hg], IDWG [(3.8±1.2) vs (2.1±0.9)kg], UF rate [,(15.3±0.2) vs (9.1±0.4)mL/(h . kg)], iPTH [(564.5±68.7) vs (365.9± 46.9)ng/L], the treatment rate (100% vs 87% ) and mean doses [(10 000±1546) vs (8856±1287)U/W] of eryth- ropoietin ( EPO), average hospitalization rate [ (0.7± 0.2 ) vs (0.3 ± 0.3 ) times/year], relative cardiovascular and cerebrovascular complications incidence (64 %vs 12 %) were all higher in group A (P〈0.05). In terms of single dialysis, the IDWG, uhrafiltration rate, average heart rate of intradialysis, pre-dialysis mean arterial blood pressure(PreMAP) of the cases without IDH were lower than those with IDH (P〈0.05). Multivariate Losgistic regres- sion analysis revealed that IDWG, dialysis frequency, average heart rate of intradialysis, PreMAP, ultrafiltration rate were influence factors of IDH. Conclusions IDH is correlated with IDWG, PreMAP, average heart rate of in- tradialysis, and dialysis adequacy.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2012年第12期1169-1172,共4页 Chinese Journal of Hypertension
基金 福建医科大学临床医学重点学科(高血压学)(XK201107)
关键词 血液透析 高血压 影响因素 Hemodialysis Hypertension Influencing factors
  • 相关文献

参考文献12

  • 1吕玉风,刘必成,邢昌赢,张苗,孙伟,楼季庄,张晓良,王艳丽.维持性血液透析合并高血压治疗状况的多中心调查[J].中国血液净化,2007,6(4):184-187. 被引量:18
  • 2李秀季,黄雯.血液透析过程相关性高血压[J].中国血液净化,2009,8(10):560-562. 被引量:7
  • 3Cirit M, Akcicek F, Terzioglu E, et al. 'Paradoxical" rise in blood pressure during ultrafiltration in dialysis patients[J]. Nephrol Dial Transplant, 1995,10(8) : 1417-1420.
  • 4陈灏珠.实用内科学[M]12版.北京:人民卫生出版社,2005.1746-1750.
  • 5王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:8262.
  • 6王磊,王梅.维持性血液透析患者高血压的控制及其相关因素分析[J].中国血液净化,2009,8(2):84-87. 被引量:54
  • 7中国人民解放军肾脏病专业协作组.2001例血液透析患者病因分析及高血压和贫血治疗状况[J].中国血液净化,2005,4(5):235-238. 被引量:77
  • 8Mees EJ. Rise in blood pressure during hemodialysis uhrafihra tion: a'paradoxical' phenomenon? [J].Int J Artif Organs, 1996, 19(10) :569-570.
  • 9Inrig IK, Patel UD, Toto RD, et al. Association of Blood pressure in creases during hemodialysis with 2-year mortality in incident hemodial ysis patients: a secondary analysis of the dialysis morbidity and mortal ity wave 2 study[J]. Am J Kidney Dis,2009,54(5) :881-890.
  • 10Inrig JK, Oddone EZ, Hasselblad V, et al. Association of intra dialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients[J]. Kidney 1nt,2007,71(5): 454-461.

二级参考文献65

  • 1中国人民解放军肾脏病专业协作组.2001例血液透析患者病因分析及高血压和贫血治疗状况[J].中国血液净化,2005,4(5):235-238. 被引量:77
  • 2王梅.血液透析患者高血压的治疗[J].肾脏病与透析肾移植杂志,2007,16(2):154-155. 被引量:11
  • 3冯小平,冯学亮.慢性肾功能衰竭818例病因分析[J].陕西医学杂志,1997,26(5):307-307. 被引量:3
  • 4Merlo J, Wessling A, Melaader A. Comparison of dose standard units for drug utilization studies[J]. Eur J Clin Pharmacol, 1996,50:27-30.
  • 5Akeda A, Toda T, Fujii T, et al. Discordance of influence of hypertension on mortality and cardiovascular risk in hemodialysis patients[J]. Am J Kidney Dis, 2005,45:112- 118.
  • 6Foley RN, Herzog CA. United States Renal Data System. Bloodpressure and long-term mortality in Onited States hemodialysis patients: USRDS Waves 3 and 4 Study[J]. Kidney Int, 2002,62(5):1784-1790.
  • 7Mittal SK, Kowalski E, Trenkle J, et al. Prevalence of hypertension in a hemodialysis population[J]. Clin Nephrol, 1999, 51(2):77-82.
  • 8Agarwal R, Nissenson AR, Batlle D, et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States[J]. Am J Med, 2003, 115:291-297.
  • 9Agarwal R,L ewis RR:Prediction of hypertension in chronic hemodialysis patients[J]. Kidney Int, 2001, 60:1982-1989.
  • 10Watts RJ. Hazardous Wastes: Sources, Pathways, Re-ceptors [J]. New York: John Wiley, 1997:116-119.

共引文献1706

同被引文献87

引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部